KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 123 filers reported holding KEROS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 292,833 | $17,134,000 | 5.65% |
Deep Track Capital, LP | 1,300,000 | $76,063,000 | 5.37% |
Octagon Capital Advisors LP | 340,214 | $19,906,000 | 3.87% |
Opaleye Management Inc. | 265,750 | $15,549,000 | 3.30% |
First Light Asset Management, LLC | 552,098 | $32,303,000 | 2.31% |
Altium Capital Management LP | 116,000 | $6,787,000 | 1.87% |
Nantahala Capital Management | 796,698 | $46,615,000 | 1.64% |
Orbimed Advisors | 1,679,417 | $98,263,000 | 1.26% |
Darwin Global Management, Ltd. | 111,500 | $6,524,000 | 1.00% |
Parkman Healthcare Partners LLC | 69,861 | $4,088,000 | 0.90% |